134 related articles for article (PubMed ID: 16452814)
1. [Organ preservation, multimodal radical tumor therapy and reduction of therapy-related morbidity--development of diagnostics and therapy of endometrial carcinoma].
Kimmig R; Fink D; Lang U
Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):1-2. PubMed ID: 16452814
[TBL] [Abstract][Full Text] [Related]
2. Use and outcomes of minimally invasive hysterectomy for women with nonendometrioid endometrial cancers.
Nieto VL; Huang Y; Hou JY; Tergas AI; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2018 Nov; 219(5):463.e1-463.e12. PubMed ID: 30086293
[TBL] [Abstract][Full Text] [Related]
3. Contemporary issues in the management of endometrial cancer.
Barakat RR
CA Cancer J Clin; 1998; 48(5):299-314. PubMed ID: 9742896
[TBL] [Abstract][Full Text] [Related]
4. Management of Endometrial Cancer: A Review.
Suri V; Arora A
Rev Recent Clin Trials; 2015; 10(4):309-16. PubMed ID: 26411949
[TBL] [Abstract][Full Text] [Related]
5. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of minimally invasive surgery for patients with endometrial carcinoma involving the cervix.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
Int J Gynecol Cancer; 2020 May; 30(5):619-625. PubMed ID: 32276935
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy of uterine clear cell carcinoma: a review.
Xu Y; Hanna RK; Elshaikh MA
Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant postoperative treatment of endometrial cancer].
Vergote IB
Gynakologe; 1994 Apr; 27(2):84-8. PubMed ID: 8039747
[No Abstract] [Full Text] [Related]
9. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy.
Laliscia C; Cosio S; Morganti R; Mazzotti V; Fabrini MG; Paiar F; Gadducci A
Oncology; 2019; 96(5):235-241. PubMed ID: 30904907
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
12. Organ preservation and functional rehabilitation in head and neck: introduction.
Gullane PJ; O'Sullivan B
World J Surg; 2003 Jul; 27(7):804. PubMed ID: 14509510
[No Abstract] [Full Text] [Related]
13. Endometrial cancer.
Hanf V; Günthert AR; Emons G
Onkologie; 2003 Oct; 26(5):429-36. PubMed ID: 14605458
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive surgery does not impair overall survival in stage IIIC endometrial cancer patients.
Papadia A; Garbade A; Gasparri ML; Wang J; Radan AP; Mueller MD
Arch Gynecol Obstet; 2020 Feb; 301(2):585-590. PubMed ID: 31781888
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic survival of women after surgery for endometrial cancer].
Roszak A
Ginekol Pol; 1994 Sep; 65(9):486-90. PubMed ID: 7721160
[TBL] [Abstract][Full Text] [Related]
16. Impact of quality of care on racial disparities in survival for endometrial cancer.
Huang AB; Huang Y; Hur C; Tergas AI; Khoury-Collado F; Melamed A; St Clair CM; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2020 Sep; 223(3):396.e1-396.e13. PubMed ID: 32109459
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes and patterns of failure in women with stage IIIC
Lee JK; Mahan M; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
[TBL] [Abstract][Full Text] [Related]
18. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K; Kucukali T
Int J Gynecol Cancer; 2002; 12(5):448-53. PubMed ID: 12366661
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
20. Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?
Lan C; Huang X; Huang Q; Wang Y; Gu H; Li Y; Liu J
Int J Gynecol Cancer; 2015 Oct; 25(8):1445-52. PubMed ID: 26397067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]